In clinical practice, the ACB scale is used to assess the risk of cognitive impairment in patients who are prescribed multiple medications with anticholinergic properties. Healthcare providers can calculate the total ACB score for a patient by summing the scores of all prescribed anticholinergic drugs. This score helps in identifying patients at high risk and guiding decisions to modify or discontinue certain medications to reduce the anticholinergic burden.